Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes
| Autor: | Michele I. Morris, Jeffrey M. Tessier, Rachel Miller, Robin K. Avery, David B. Banach, J. Stephen Dummer, Henry B. Randall, George Alangaden, Erika D. Lease, Andrea Zimmer, Costi D. Sifri, Shirish Huprikar, W Cedric, Christine E. Koval, Jose Montero, Nina Singh, Kevin S. Gregg, Emily A. Blumberg, Raymund R. Razonable, Darin Ostrander, Miloni Shroff, Hsin-Yun Sun, Fernanda P. Silveira, Ahlaam Alynbiawi, Jade Le, Marilyn M. Wagener, Albert J. Eid |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Liver Cirrhosis
Male medicine.medical_specialty Antifungal Agents Cirrhosis medicine.medical_treatment Liver transplantation Risk Factors Internal medicine medicine Humans In patient Fluconazole Transplantation business.industry Cryptococcosis Middle Aged Prognosis medicine.disease Transplant Recipients Optimal management Liver Transplantation Surgery Treatment Outcome Liver Multicenter study Disease Progression Female business medicine.drug |
| Zdroj: | Transplantation. 99:2132-2141 |
| ISSN: | 0041-1337 |
| DOI: | 10.1097/tp.0000000000000690 |
| Popis: | The outcomes and optimal management of cirrhotic patients who develop cryptococcosis before transplantation are not fully known.We conducted a multicenter study involving consecutive patients with cirrhosis and cryptococcosis between January 2000 and March 2014. Data collected were generated as standard of care.In all, 112 patients were followed until death or up to 9 years. Disseminated disease and fungemia were present in 76.8% (86/112) and 90-day mortality was 57.1% (64/112). Of the 39 patients listed for transplant, 20.5% (8) underwent liver transplantation, including 2 with active but unrecognized disease before transplantation. Median duration of pretransplant antifungal therapy and posttransplant therapy was 43 days (interquartile range, 8-130 days) and 272 days (interquartile range, 180-630 days), respectively. Transplantation was associated with lower mortality (P = 0.002). None of the transplant recipients developed disease progression during the median follow-up of 3.5 years with a survival rate of 87.5%.Cryptococcosis in patients with cirrhosis has grave prognosis. Our findings suggest that transplantation after recent cryptococcal disease may not be a categorical exclusion and may be cautiously undertaken in liver transplant candidates who are otherwise deemed clinically stable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|